nature.com· Asher Mullard·· 2 days agoPickScore82
FDA approves hepatitis B antisense drug
FDA approves hepatitis B antisense drug
In brief
The FDA has approved GSK's antisense drug bepirovirsen (Hibsago), used together with existing antiviral therapy, for chronic hepatitis B virus infection in adults without cirrhosis. DOI: 10.1038/d41573-026-00166-7
Why it matters
The brief specifies use with existing antiviral therapy and only in adults without cirrhosis, so readers can place the drug in chronic HBV treatment.
Source: nature.com · nature.com